NEW YORK (GenomeWeb) – Sigma-Aldrich today reported third quarter revenue growth of 2 percent year over year as it nears the completion of a deal to be acquired by Merck KGaA.

The St. Louis-based research tools and chemicals firm reported total revenues of $703 million for the three months ended Sept. 30, up from $690 million for the third quarter of 2014. On an organic basis, sales were up 9 percent year over year, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.